Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine Enhancement of rTMS for Refractory Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04352621

Organisation Name: University of Cincinnati

Overal Status: Not yet recruiting

Start Date: May 1, 2020

Last Update: April 20, 2020

Lead Sponsor: University of Cincinnati

Brief Summary: An open label study to assess the safety, tolerability, and effects of intranasal Ketamine in combination with rTMS for patients with treatment-resistant major depressive disorder (TRD). Patients will be given a dose of ketamine followed by 6 weeks of rTMS treatment.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.37618589401245